Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
During your first week, your body encounters this novel signaling pattern for the first time, triggering nausea and digestive adjustments as your system recalibrates
This is important because: Not everyone wants or tolerates medication Not everyone qualifies for GLP-1s Some patients are looking for alternative starting points It can also be a helpful add-on for patients who need additional support but are limited by medication side effects Like any treatment, it is not for everyone
In the Wegovy clinical trials, 2% of users experienced a rare skin sensitivity reaction that feels like burning or tingling (dysesthesia). Contact your health provider for advice if this happens
Novo Nordisk intends to use the SCALE Kids trial to expand the Saxenda (liraglutide) label for children six years or older with obesity
Pre-clinical studies have shown that the two signals converge additively, producing larger body-weight reductions than either peptide alone and without reciprocal attenuation of glucoregulatory effects
[PubMed: 8786810] 236
